Japan-based healthcare startup Ubie has raised around $18.7 million in a fresh funding round, the media reported.
Ubie will use the funds raised in its Series B funding round to expand its research and development capabilities.
The startup also plans to use the funds to add it to its workforce and scale its products. It will also enable Ubie to quickly scale its Hospital SaaS (Software as a Service) product “Ubie for Hospital”, and its consumer application, AI symptom checker “Ubie”, to reach new partners and customers nationwide.
Reportedly, Ubie is also mulling launching its business in other markets.
The funding round for the startup was led by led by Suzuken, a listed pharmaceutical distributor company in Japan.
Ubie co-founder and medical doctor, Yoshinori Abe told the media, “I strongly believe that our company is going to play a crucial role in combating the current crisis. During these uncertain times, our mission; “to develop a healthcare guide for everyone” has never been more important. With our AI-based symptom checker and clinical decision support technology, which we have been developing since 2013, we will make healthcare accessible to everyone by creating a “search engine” for healthcare. We are going to go full throttle to realize our company mission as soon as possible, with help from this fresh round of funding, and with the full support of all our stakeholders.”
Established in 2017 by Yoshinori Abe and Kota Kubo, Ubie raised around $10 million in its previous funding round.
In May 2018, the startup raised an estimated $2.7 million in funding led by Kanden Venture Management (KVM), which is a corporate venture capital of The Kansai Electric Power Company.